Treatment of relapsed acute myeloid leukaemia after allogeneic bone marrow transplantation with combination chemotherapy of cytarabine, idarubicin plus etoposide and subsequent donor leukocyte infusion: a prospective study

被引：0
|
作者：
Choi, SJ [1 ]
Lee, JH [1 ]
Lee, JH [1 ]
Kim, S [1 ]
Seol, M [1 ]
Lee, YS [1 ]
Lee, JS [1 ]
Kim, WK [1 ]
Lee, KH [1 ]
机构：
[1] Asan Med Ctr, Seoul, South Korea
来源：
BONE MARROW TRANSPLANTATION | 2004年 / 33卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S232 / S233
页数：2
相关论文
共 50 条
  • [1] Treatment of relapsed acute myeloid leukemia after allogeneic bone marrow transplantation with combination chemotherapy of cytarabine, idarubicin plus etoposide and subsequent donor leukocyte infusion: A prospective study.
    Choi, SJ
    Lee, JH
    Lee, JH
    Kim, S
    Seol, M
    Lee, YS
    Lee, JS
    Kim, WK
    Lee, KH
    BLOOD, 2003, 102 (11) : 457B - 457B
  • [2] Combination chemotherapy of intermediate-dose cytarabine, idarubicin, plus etoposide and subsequent mobilized donor leukocyte infusion for relapsed acute leukemia after allogeneic bone marrow transplantation
    Lee, JH
    Lee, KH
    Kim, S
    Seol, M
    Kim, SH
    Kim, WK
    Lee, JS
    LEUKEMIA RESEARCH, 2001, 25 (04) : 305 - 312
  • [3] Donor leukocyte infusions for treatment of relapsed acute myeloid leukemia after allogeneic bone marrow transplantation
    Fores, R
    DiezMartin, JL
    Briz, M
    Cabrera, JR
    Sanjuan, I
    Regidor, C
    GarciaTalavera, J
    Fernandez, MN
    BONE MARROW TRANSPLANTATION, 1996, 17 (03) : 439 - 441
  • [4] Treatment of relapsed acute lymphoblastic leukemia after allogeneic bone marrow transplantation with chemotherapy followed by G-CSF-primed donor leukocyte infusion: a prospective study
    Choi, SJ
    Lee, JH
    Lee, JH
    Kim, S
    Lee, YS
    Seol, M
    Ryu, SG
    Lee, JS
    Kim, WK
    Jang, S
    Park, CJ
    Chi, HS
    Lee, KH
    BONE MARROW TRANSPLANTATION, 2005, 36 (02) : 163 - 169
  • [5] Treatment of relapsed acute lymphoblastic leukemia after allogeneic bone marrow transplantation with chemotherapy followed by G-CSF-primed donor leukocyte infusion: a prospective study
    S-J Choi
    J-H Lee
    J-H Lee
    S Kim
    Y-S Lee
    M Seol
    S-G Ryu
    J-S Lee
    W-K Kim
    S Jang
    C-J Park
    H-S Chi
    K-H Lee
    Bone Marrow Transplantation, 2005, 36 : 163 - 169
  • [6] Decitabine in relapsed acute myeloid leukaemia after allogeneic bone marrow transplantation
    Ganguly, S.
    Amin, M.
    Aljitawi, O.
    Abhyankar, S.
    McGuirk, J.
    BONE MARROW TRANSPLANTATION, 2012, 47 : S102 - S103
  • [7] Donor leukocyte infusion after allogeneic bone marrow transplantation was not effective for relapsed rhabdomyosarcoma
    H Moritake
    Y Ikuno
    H Tasaka
    H Koga
    S Miyazaki
    J Okamura
    Bone Marrow Transplantation, 1998, 21 : 725 - 726
  • [8] Donor leukocyte infusion after allogeneic bone marrow transplantation was not effective for relapsed rhabdomyosarcoma
    Moritake, H
    Ikuno, Y
    Tasaka, H
    Koga, H
    Miyazaki, S
    Okamura, J
    BONE MARROW TRANSPLANTATION, 1998, 21 (07) : 725 - 726
  • [9] Allogeneic bone marrow transplantation for relapsed acute myeloid leukaemia (AML)
    Grigg, A
    Bardy, P
    Szer, J
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1996, 26 (04): : 570 - 571
  • [10] Donor leukocyte infusion as salvage therapy in an adult with relapsed acute lymphoblastic leukemia after allogeneic bone marrow transplantation
    Chang, CS
    Lin, SF
    Liu, TC
    Huang, SM
    Chen, TP
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 1998, 97 (01) : 55 - 58
12345